Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
NCT05881213
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Type II Diabetes
Interventions
DRUG:
CKD-378 (low-dose)
Sponsor
Chong Kun Dang Pharmaceutical